Tiziana Life Sciences Statistics
Total Valuation
TLSA has a market cap or net worth of $99.82 million. The enterprise value is $101.51 million.
Important Dates
The next estimated earnings date is Friday, December 27, 2024, before market open.
Earnings Date | Dec 27, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TLSA has 102.46 million shares outstanding. The number of shares has decreased by -0.78% in one year.
Current Share Class | 102.46M |
Shares Outstanding | 102.46M |
Shares Change (YoY) | -0.78% |
Shares Change (QoQ) | +0.42% |
Owned by Insiders (%) | 38.40% |
Owned by Institutions (%) | 1.02% |
Float | 63.12M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 55.24 |
P/TBV Ratio | 55.24 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.85, with a Debt / Equity ratio of 0.10.
Current Ratio | 0.85 |
Quick Ratio | 0.82 |
Debt / Equity | 0.10 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -3,159.80 |
Financial Efficiency
Return on equity (ROE) is -181.23% and return on invested capital (ROIC) is -125.93%.
Return on Equity (ROE) | -181.23% |
Return on Assets (ROA) | -69.58% |
Return on Capital (ROIC) | -125.93% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.53M |
Employee Count | 9 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | -2.88M |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +77.97% in the last 52 weeks. The beta is 0.18, so TLSA's price volatility has been lower than the market average.
Beta (5Y) | 0.18 |
52-Week Price Change | +77.97% |
50-Day Moving Average | 0.95 |
200-Day Moving Average | 0.82 |
Relative Strength Index (RSI) | 53.83 |
Average Volume (20 Days) | 430,085 |
Short Selling Information
Short Interest | 241,892 |
Short Previous Month | 53,735 |
Short % of Shares Out | 0.38% |
Short % of Float | n/a |
Short Ratio (days to cover) | 0.85 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -15.80M |
Pretax Income | -17.24M |
Net Income | -13.73M |
EBITDA | -15.79M |
EBIT | -15.80M |
Earnings Per Share (EPS) | -$0.13 |
Full Income Statement Balance Sheet
The company has $1.13 million in cash and $179,000 in debt, giving a net cash position of $951,000 or $0.01 per share.
Cash & Cash Equivalents | 1.13M |
Total Debt | 179,000 |
Net Cash | 951,000 |
Net Cash Per Share | $0.01 |
Equity (Book Value) | 1.86M |
Book Value Per Share | 0.02 |
Working Capital | -1.32M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$3.91 million and capital expenditures -$14,000, giving a free cash flow of -$3.92 million.
Operating Cash Flow | -3.91M |
Capital Expenditures | -14,000 |
Free Cash Flow | -3.92M |
FCF Per Share | -$0.04 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |